Delivery Order SPE2DR25D3012-SPE2DR26F4C6H
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,590.37 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of LONSURF (20 mg–8.19 mg tablets in quantities of 20) with completion scheduled for December 23, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award based on demonstrated capability. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $10,248.32 and firm fixed pricing. The contract is non-set-aside and represents a competitively awarded delivery order, with an ultimate completion date of November 24, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $21.6K to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Lonsurf (15 mg-6.14 mg tablets, 40-count packaging) with a completion date of December 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lonsurf (15 mg-6.14 mg tablets, 60-count packages) with a ceiling value of $23,055.99 under a firm fixed-price contract. This is a non-set-aside, competitively awarded delivery order supporting federal pharmaceutical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Lonsurf (a cancer treatment medication) in tablet form, with a contract ceiling value of $3,406.92 and an ultimate completion date of November 13, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation...
- This is a $7,685.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LONSURF 15 MG-6.14 MG tablets, which are used for medical treatment. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Lonsurf (20 mg-8.19 mg tablets) in quantities of 40 units, with a contract ceiling value of $14,248.28. This is a firm fixed-price delivery order with an ultimate completion date of December 5, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,378.67 firm fixed price delivery order to Amerisourcebergen Drug Corp, a leading pharmaceutical distributor, for the supply of LONSURF 20 MG-8.19 MG TABLET 40S. This order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential total value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of LONSURF (trifluridine/tipiracil) 20 mg-8.19 mg tablets in a quantity of 60 tablets. This is a competitively awarded, non-set-aside delivery order with a ceiling value of $21,442.28 under firm fixed pricing. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is expected...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,092.24, is for the delivery of LONSURF 15 MG-6.14 MG tablets. The contract has an ultimate completion date of April 22, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4C6HDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,590.37 to AmerisourceBergen Drug Corp for LONSURF (20 mg-8.19 mg tablets, quantity 20) with an ultimate completion date of December 23, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The DLA Troop Support Medical is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 12/1/25 |